Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19


Study Number
679720
Phase
N/A
Purpose

This expanded access program will provide access to investigational convalescent plasma for patients in acute care facilities infected with SARS-CoV-2 who have severe or life-threatening COVID-19, or who are judged by a healthcare provider to be at high risk of progression to severe or life-threatening disease.

Full Title

Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19

ClinicalTrials.Gov ID
NCT04338360

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.